T 1099/21 du 15.03.2023
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:2023:T109921.20230315
- Date de la décision
- 15 mars 2023
- Numéro de l'affaire
- T 1099/21
- Requête en révision de
- -
- Numéro de la demande
- 07250962.3
- Classe de la CIB
- C09D 5/16A01N 43/80A01N 25/28A01P 15/00
- Langue de la procédure
- Anglais
- Distribution
- Non distribuées (D)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- Résumé de EPC2000 Art 123(2)
- Titre de la demande
- BLENDS OF ENCAPSULATED BIOCIDES
- Nom du demandeur
- Rohm and Haas Company
- Nom de l'opposant
- Thor GmbH
- Chambre
- 3.3.02
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 100(c)European Patent Convention Art 123(2)
- Mots-clés
- Grounds for opposition - added subject-matter
- Exergue
- Any unclarity that may arise from an ambiguity in an application as filed is to the detriment of a patent proprietor, who is ultimately responsible for the drafting of the application as filed and its claims. The fact that a feature in the application as filed is unclear cannot therefore justify or excuse the complete deletion of the unclear feature or its replacement by another feature if this results in an extension beyond the content of the application as filed. What prompted a patent proprietor to make a particular amendment to the claims cannot have any influence on the outcome of the assessment of the ground for opposition under Article 100(c) EPC (point 8 of the Reasons).
- Affaires citées
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.